ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
PharmaTher Holdings Ltd

PharmaTher Holdings Ltd (PHRM)

0.225
0.00
(0.00%)
Closed 26 December 8:00AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.225
Bid
0.215
Offer
0.24
Volume
4,500
0.225 Day's Range 0.225
0.17 52 Week Range 0.43
Previous Close
0.225
Open
0.225
Last Trade
3500
@
0.225
Last Trade Time
Average Volume (3m)
111,649
Financial Volume
-
VWAP
-

PHRM Latest News

PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch

 PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch Delivering psilocybin via microneedle patch unlocks potential for desired dosage forms and pharmacokinetic profiles...

PharmaTher Enters into Research Collaboration Agreement with Revive Therapeutics for Development of Psilocybin Microneedle Patch

 PharmaTher Enters into Research Collaboration Agreement with Revive Therapeutics for Development of Psilocybin Microneedle Patch  Focusing on partnership model for MicroDose-MN™ and...

PharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine Products

 PharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine Products Leading U.S.-based CDMO to manufacture PharmaTher's proprietary ketamine products for FDA Phase 3...

PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Complex Regional Pain Syndrome

 PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Complex Regional Pain Syndrome Achieving its second FDA orphan drug designation with ketamine.Building a proprietary...

PharmaTher Added to the North American Psychedelics Index and First Psychedelic Exchange Traded Fund

 PharmaTher Added to the North American Psychedelics Index and First Psychedelic Exchange Traded Fund TORONTO, September 21, 2021 -- InvestorsHub NewsWire -- PharmaTher Holdings Ltd. (the...

PharmaTher Provides Product Pipeline Updates and Anticipated Milestones for Q4-2021 and 2022

  PharmaTher Provides Product Pipeline Updates and Anticipated Milestones for Q4-2021 and 2022   10 clinical sites selected to participate in the FDA Phase 2 clinical...

PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Amyotrophic Lateral Sclerosis

 PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Amyotrophic Lateral Sclerosis Focusing on becoming a global leader in prescription-based ketamine productsAdvancing to a Phase...

PharmaTher Expands Psychedelic Patent Portfolio with Filing of U.S. Patent Application for Novel Ketamine Formulation

 PharmaTher Expands Psychedelic Patent Portfolio with Filing of U.S. Patent Application for Novel Ketamine Formulation Strengthens position to become a leader in the intradermal delivery of FDA...

PharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET™ To Treat Depression

  PharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET™ To Treat Depression   Potential for FDA 505(b)(2) regulatory pathway approval and...

PharmaTher Files for FDA Orphan Drug Designation for Ketamine to Treat Lou Gehrig's Disease

  PharmaTher Files for FDA Orphan Drug Designation for Ketamine to Treat Lou Gehrig's Disease   TORONTO, May 25, 2021 -- InvestorsHub NewsWire -- PharmaTher Holdings...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.2250.2350.2705550.22784592CS
4-0.015-6.250.240.280.2751510.23582446CS
12-0.025-100.250.3150.1851116490.23707439CS
26000.2250.330.18794470.2384383CS
52-0.065-22.41379310340.290.430.17865190.24972322CS
156-0.125-35.71428571430.350.430.0551031380.18937152CS
260-0.03-11.76470588240.2551.240.052014590.34858075CS

PHRM - Frequently Asked Questions (FAQ)

What is the current PharmaTher share price?
The current share price of PharmaTher is $ 0.225
What is the 1 year trading range for PharmaTher share price?
PharmaTher has traded in the range of $ 0.17 to $ 0.43 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CNTRCENTR Brands Corp
$ 0.15
(114.29%)
31.1k
BEEBee Vectoring Technologies International Inc
$ 0.01
(100.00%)
108.8k
AWRAurwest Resources Corporation
$ 0.01
(100.00%)
20k
WINCommon Stock
$ 0.015
(50.00%)
2.6k
RXMRockex Mining Corporation
$ 0.015
(50.00%)
1.73k
HROHero Innovation Group Inc
$ 0.005
(-66.67%)
100k
NXU.XNexco Resources Inc
$ 0.005
(-50.00%)
4k
PUMPStock Trend Capital Inc
$ 0.005
(-50.00%)
193.1k
WBIOWPD Pharmaceuticals Inc
$ 0.01
(-50.00%)
119k
AUMCAuric Minerals Corp
$ 1.72
(-43.23%)
566.38k
QIMCQuebec Innovative Materials Corp
$ 0.08
(-11.11%)
2.63M
SOLSOL Global Investments Corp
$ 0.38
(4.11%)
976.71k
NUENU E Power Corp
$ 0.35
(7.69%)
923.5k
IDKThreeD Capital Inc
$ 0.165
(-10.81%)
854.58k
SPODSpod Lithium Corp
$ 0.03
(-14.29%)
822.58k

Discussion

View Full Feed
Seminole Red Seminole Red 10 minutes ago
https://scontent-mia3-1.xx.fbcdn.net/v/t39.30808-6/471276104_882978274048002_3316470983360739570_n.jpg?_nc_cat=111&ccb=1-7&_nc_sid=127cfc&_nc_ohc=dT4WqVfoee0Q7kNvgElaTl_&_nc_zt=23&_nc_ht=scontent-mia3-1.xx&_nc_gid=A8k3gs7tYPx0EVIlzN-Pcxs&oh=00_AYB4SFr1xl_HIP90B9z9G9_VzgRTy_IzVgSgj6WBXrUyFA&oe=6772C8
flipper44 flipper44 11 minutes ago
I don’t think people read this October 2024 follow up abstract. I’d suggest rereading the abstract until one gets the entire upshot.

https://aacrjournals.org/cancerres/article-abstract/84/19/3130/748704/Hyperactive-Dendritc-Cells-Redirect-Aged-Antitumor?redirectedFrom=fulltext
NWBO
jeunke22 jeunke22 28 minutes ago
Please realize there is a perfect alternative from IBM to POET’s interposers. In the current political climate POET’s ties with China pose a serious business risk. Apparently US institutional investors realize this because their ownership in POET is almost 80% lower than in Lightwave which has 1/3 o
LWLG
Seminole Red Seminole Red 35 minutes ago
Education Department Cancels Loan Cancellation Scheme
Adam Kissel | December 20, 2024

The U.S. Department of Education announced today that it will be withdrawing both parts of its Plan C for student loan cancellation. One part involves various ways the department would have de
stock1ace1 stock1ace1 47 minutes ago
Started a new telegram for stock plays join here -> https://t.me/+YpRHvw-vdyA0MTZh
Zorax Zorax 49 minutes ago
There's no way beer that old would still be good.
But the container would be worth a fortune.

sarcasm- satire.
stock1ace1 stock1ace1 49 minutes ago
SNPX $3.04 ($19.6 Million cash on balance sheet with 1.3 million float)
$19,600,000 / 1,300,000 float = $15 cash per share !

They also formed an independent Special Committee to explore strategic opportunities to create and enhance value for investors on Dec 20, 2024
stock1ace1 stock1ace1 49 minutes ago
SNPX $3.04 ($19.6 Million cash on balance sheet with 1.3 million float)
$19,600,000 / 1,300,000 float = $15 cash per share

They also formed an independent Special Committee to explore strategic opportunities to create and enhance value for investors on Dec 20, 2024
ReasearchThis ReasearchThis 56 minutes ago
CDers will eventually run AXXA to over a dollar.
.
I am sure some of you remember when brokerage companies changed $5 more or less. To make a trade. So how did it get to the point, That buying or selling 200 shares of axxa/any stock for $.0008 cents makes any sense at all.? That is w
AXXA
green maschine green maschine 59 minutes ago
Certain Warrants of Tonix Pharmaceuticals Holding Corp. are subject to a Lock-Up Agreement Ending TODAY. Tnxp currently @ .4031
https://www.marketscreener.com/quote/stock/TONIX-PHARMACEUTICALS-HOL-154457268/news/Certain-Warrants-of-Tonix-Pharmaceuticals-Holding-Corp-are-subject-to-a-Lock-Up-A
TNXP
nowwhat2 nowwhat2 1 hour ago
117,000 has been on my radar as well.......That's where I've estimated THIS to be ;

But yer sayin' ?
No way we slug up to only just that ?


https://investorshub.advfn.com/uimage/uploads/2024/12/25/lsnvxBTC_121212_15_HYPER_EOY_TARGET_117.jpg
BTCUSD
mrfence mrfence 1 hour ago
Say Marie, are the poor allowed to rent, and eat cake too?
Good, let the poor rent.
FNMA
Homebrew Homebrew 1 hour ago
Of course a few get shorted...duh. Few and far between. But yelling "shorts" on every worthless Stinky-Pinky is laughable.
SAPX
nowwhat2 nowwhat2 1 hour ago
Channel Of Destiny / 100k

https://investorshub.advfn.com/uimage/uploads/2024/12/26/evyvgxrp_121212_25_15d_7am_CHAN_OF_DESTINY.jpg


14 HOURS LATER

https://investorshub.advfn.com/uimage/uploads/2024/12/26/mggdjxrp_121212_25_15d_930PM_CHAN_OF_DESTINY.
XRPUSD
wadegarret wadegarret 1 hour ago
Hope high flying tech fades & value shines

in 2025. That would surely be a healthier market IMO.
boi568 boi568 2 hours ago
I have now read the linked article, which documents the lengths of time the FDA can go with posting draft guidances that stay up on their website practically forever without any progress. The author's point is that in those cases the FDA is using the draft as its unofficial, final word -- which is a
AVXL
ducci1 ducci1 2 hours ago
ES & SPX 15--30--60 min Red Lines All Retaken---Back to Red Line Bullish !!
SPY
dstock07734 dstock07734 2 hours ago
Sounds like you are ready for UK approval.

No one is giving upfront non dilutive cash to NWBO
What a ludicrous prediction! You and your buddy really need to do homework on the company before betting against it.

Now read the following article to prime yourself fir
NWBO
ORCA ORCA 2 hours ago
Q1 REPORT IS DUE ANY DAY NOW.LET'S HOPE IT WILL BE GOOD.
RJDG
ORCA ORCA 2 hours ago
HEY DIRTY BAG.EVERYTHING FALLS ON MY LAP.
JNSH

Your Recent History

Delayed Upgrade Clock